These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 17515941

  • 21. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features.
    Valentini G, Cuomo G, Abignano G, Petrillo A, Vettori S, Capasso A, Cozzolino D, Del Genio G, Santoriello C.
    Rheumatology (Oxford); 2011 Feb; 50(2):317-23. PubMed ID: 20562195
    [Abstract] [Full Text] [Related]

  • 22. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.
    Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumánovics G, Coleiro B, Feierl E, Szucs G, Von Mühlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kötter I, Simsek I, de la Pena Lefebvre PG, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA.
    Ann Rheum Dis; 2010 Oct; 69(10):1809-15. PubMed ID: 20551155
    [Abstract] [Full Text] [Related]

  • 23. Demography, clinical and laboratory features of systemic sclerosis in a Malaysian rheumatology centre.
    Pagalavan L, Ong SG.
    Med J Malaysia; 2007 Jun; 62(2):117-21. PubMed ID: 18705442
    [Abstract] [Full Text] [Related]

  • 24. Patients with scleroderma may have increased risk of osteoporosis. A comparison to rheumatoid arthritis and noninflammatory musculoskeletal conditions.
    Yuen SY, Rochwerg B, Ouimet J, Pope JE.
    J Rheumatol; 2008 Jun; 35(6):1073-8. PubMed ID: 18412305
    [Abstract] [Full Text] [Related]

  • 25. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR).
    Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M, EUSTAR Co-Authors.
    Ann Rheum Dis; 2009 May; 68(5):620-8. PubMed ID: 19147617
    [Abstract] [Full Text] [Related]

  • 26. Severe gastrointestinal involvement in systemic sclerosis: report of five cases and review of the literature.
    Jaovisidha K, Csuka ME, Almagro UA, Soergel KH.
    Semin Arthritis Rheum; 2005 Feb; 34(4):689-702. PubMed ID: 15692963
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group.
    Pope J, Harding S, Khimdas S, Bonner A, Canadian Scleroderma Research Group, Baron M.
    J Rheumatol; 2012 Mar; 39(3):524-31. PubMed ID: 22247347
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pulmonary-renal syndrome in systemic sclerosis.
    Bar J, Ehrenfeld M, Rozenman J, Perelman M, Sidi Y, Gur H.
    Semin Arthritis Rheum; 2001 Jun; 30(6):403-10. PubMed ID: 11404823
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. How to manage patients with cardiopulmonary disease?
    Kao AH, Manzi S.
    Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):211-27. PubMed ID: 12041950
    [Abstract] [Full Text] [Related]

  • 35. [Visceral manifestations of diffuse scleroderma].
    Suţeanu S, Moise A, Stoicescu M.
    Med Interne; 1988 Apr; 26(2):125-38. PubMed ID: 3291079
    [No Abstract] [Full Text] [Related]

  • 36. Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.
    Proudman SM, Stevens WM, Sahhar J, Celermajer D.
    Intern Med J; 2007 Jul; 37(7):485-94. PubMed ID: 17547726
    [Abstract] [Full Text] [Related]

  • 37. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC, Highland KB, Silver RM, Strange C.
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [Abstract] [Full Text] [Related]

  • 38. Geographical variation of disease manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research (EUSTAR) group database.
    Walker UA, Tyndall A, Czirják L, Denton CP, Farge-Bancel D, Kowal-Bielecka O, Müller-Ladner U, Matucci-Cerinic M, EUSTAR co-authors.
    Ann Rheum Dis; 2009 Jun; 68(6):856-62. PubMed ID: 18625615
    [Abstract] [Full Text] [Related]

  • 39. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D, Czömpöly T, Berki T, Minier T, Peti A, Tóth E, Czirják L, Németh P.
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.